These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 20598042
21. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance. Wang L, Ma J, Liu F, Yu Q, Chu G, Perkins AC, Li Y. Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732 [Abstract] [Full Text] [Related]
22. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma. Masaki Y, Oka M, Ogura Y, Ueno T, Nishihara K, Tangoku A, Takahashi M, Yamamoto M, Irimura T. Hepatogastroenterology; 1999 Jun; 46(28):2240-5. PubMed ID: 10521973 [Abstract] [Full Text] [Related]
23. Mucin expression in nonneoplastic and neoplastic glandular epithelia of the uterine cervix. Zhao S, Hayasaka T, Osakabe M, Kato N, Nakahara K, Kurachi H, Fukase M, Katayama Y, Yaegashi N, Motoyama T. Int J Gynecol Pathol; 2003 Oct; 22(4):393-7. PubMed ID: 14501822 [Abstract] [Full Text] [Related]
24. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope. Baldus SE, Wienand JR, Werner JP, Landsberg S, Drebber U, Hanisch FG, Dienes HP. Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224 [Abstract] [Full Text] [Related]
26. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Kim YB, Kim GE, Pyo HR, Cho NH, Keum KC, Lee CG, Seong J, Suh CO, Park TK. Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):822-9. PubMed ID: 15465199 [Abstract] [Full Text] [Related]
27. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung. Awaya H, Takeshima Y, Yamasaki M, Inai K. Am J Clin Pathol; 2004 May 01; 121(5):644-53. PubMed ID: 15151204 [Abstract] [Full Text] [Related]
28. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Kaku T, Sonoda K, Kamura T, Hirakawa T, Sakai K, Amada S, Ogawa S, Kobayashi H, Nakashima M, Watanabe T, Nakano H. Clin Cancer Res; 1999 Jun 01; 5(6):1449-53. PubMed ID: 10389931 [Abstract] [Full Text] [Related]
29. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. Dong Y, Walsh MD, Cummings MC, Wright RG, Khoo SK, Parsons PG, McGuckin MA. J Pathol; 1997 Nov 01; 183(3):311-7. PubMed ID: 9422987 [Abstract] [Full Text] [Related]
30. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT). Ueda M, Miura Y, Kunihiro O, Ishikawa T, Ichikawa Y, Endo I, Sekido H, Togo S, Shimada H. Hepatogastroenterology; 2005 Nov 01; 52(62):398-403. PubMed ID: 15816444 [Abstract] [Full Text] [Related]
31. Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervix. Kasamatsu T, Onda T, Sasajima Y, Kato T, Ikeda S, Ishikawa M, Tsuda H. Gynecol Oncol; 2009 Dec 01; 115(3):488-92. PubMed ID: 19767067 [Abstract] [Full Text] [Related]
32. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas. Wang JY, Chang CT, Hsieh JS, Lee LW, Huang TJ, Chai CY, Lin SR. J Surg Oncol; 2003 Aug 01; 83(4):253-60. PubMed ID: 12884239 [Abstract] [Full Text] [Related]
33. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma]. Yang R, Feng J, Fang XZ, Bai F, Cheng YX, Liu C, Zhu W, Li L. Zhonghua Fu Chan Ke Za Zhi; 2006 Jul 01; 41(7):459-63. PubMed ID: 17083811 [Abstract] [Full Text] [Related]
34. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC, Gynecologic Oncology Group. Cancer; 2008 May 15; 112(10):2202-10. PubMed ID: 18348296 [Abstract] [Full Text] [Related]
35. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions. Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, Porchet N, Couvelard A, Degott C, Fléjou JF. J Pathol; 2002 Aug 15; 197(5):632-7. PubMed ID: 12210083 [Abstract] [Full Text] [Related]
36. Expression of sialylated MUC1 in prostate cancer: relationship to clinical stage and prognosis. Arai T, Fujita K, Fujime M, Irimura T. Int J Urol; 2005 Jul 15; 12(7):654-61. PubMed ID: 16045558 [Abstract] [Full Text] [Related]
37. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma. Zhang Y, Yan M, He J, Sun J, Sun X. J Obstet Gynaecol Res; 2010 Oct 15; 36(5):1015-22. PubMed ID: 20846259 [Abstract] [Full Text] [Related]
38. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas. Salvesen HB, Iversen OE, Akslen LA. Clin Cancer Res; 1998 Nov 15; 4(11):2779-85. PubMed ID: 9829742 [Abstract] [Full Text] [Related]
39. Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix. Fregnani JH, Soares FA, Novik PR, Lopes A, Latorre MR. Eur J Obstet Gynecol Reprod Biol; 2008 Feb 15; 136(2):215-23. PubMed ID: 17125903 [Abstract] [Full Text] [Related]
40. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma. van der Vegt B, de Roos MA, Peterse JL, Patriarca C, Hilkens J, de Bock GH, Wesseling J. Histopathology; 2007 Sep 15; 51(3):322-35. PubMed ID: 17645748 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]